Research
Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare form of amyotrophic lateral sclerosis, or ALS.
Latest stories
Individualized Medicine
December 23, 2024
Individualized Medicine
December 19, 2024
Arizona
December 16, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community